Cetera Investment Advisers’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.03M | Sell |
|
|||||
|
2025
Q2 | $1.19M | Sell |
|
|||||
|
2025
Q1 | $1.41M | Buy |
|
|||||
|
2024
Q4 | $900K | Buy |
|
|||||
|
2024
Q3 | $634K | Sell |
|
|||||
|
2024
Q2 | $526K | Buy |
|
|||||
|
2024
Q1 | $458K | Buy |
|
|||||
|
2023
Q4 | $367K | Buy |
|
|||||
|
2023
Q3 | $179K | Buy |
|
|||||
|
2023
Q2 | $205K | Buy |
|
|||||
|
2023
Q1 | $234K | Buy |
|
|||||
|
2022
Q4 | $242K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $121K | Hold |
|
|||||
|
2022
Q1 | $143K | Sell |
|
|||||
|
2021
Q4 | $120K | Hold |
|
|||||
|
2021
Q3 | $94K | Hold |
|
|||||
|
2021
Q2 | $101K | Buy |
|
|||||
|
2021
Q1 | $79K | Buy |
|
|||||
|
2020
Q4 | $57K | Buy |
|